|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 93.25 USD | -2.05% |
|
+1.22% | +9.05% |
| 04-04 | Haemonetics Gets FDA Clearance for New TEG 6s Global Hemostasis-HN Cartridge | MT |
| 04-04 | Haemonetics Corporation Receives FDA Clearance for New TEG®? 6s Global Hemostasis - HN Cartridge | CI |
Haemonetics Corporation reported earnings results for the first quarter ended July 01, 2023. For the first quarter, the company reported sales was USD 311.33 million compared to USD 261.46 million a year ago. Net income was USD 41.04 million compared to USD 19.88 million a year ago.
Basic earnings per share from continuing operations was USD 0.81 compared to USD 0.39 a year ago. Diluted earnings per share from continuing operations was USD 0.8 compared to USD 0.38 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +9.05% | 4.74B | |
| -4.66% | 183B | |
| -1.01% | 108B | |
| -4.20% | 67.51B | |
| +2.68% | 50.67B | |
| +9.12% | 44.7B | |
| +2.95% | 40.95B | |
| +4.13% | 26.71B | |
| +3.31% | 26.8B | |
| +12.89% | 24.62B |
HAEMONETICS CORPORATION 
